Aveanna Healthcare Holdings Inc
$ 7.21
2.12%
25 Feb - close price
- Market Cap 1,506,251,000 USD
- Current Price $ 7.21
- High / Low $ 7.21 / 7.02
- Stock P/E 19.49
- Book Value 0.05
- EPS 0.37
- Next Earning Report 2026-03-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.09 %
- ROE -5.48 %
- 52 Week High 10.32
- 52 Week Low 3.67
About
Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.
Analyst Target Price
$11.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-12 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-09 | 2023-08-10 | 2023-05-11 | 2023-03-16 |
| Reported EPS | 0.15 | 0.18 | 0.1 | 0.05 | 0.02 | 0.01 | -0.03 | -0.02 | -0.03 | -0.02 | -0.05 | -0.03 |
| Estimated EPS | 0.08 | 0.04 | -0.0038 | -0.0005 | -0.01 | -0.02 | -0.05 | -0.02 | -0.03 | -0.04 | -0.06 | -0.02 |
| Surprise | 0.07 | 0.14 | 0.1038 | 0.0505 | 0.03 | 0.03 | 0.02 | 0 | 0 | 0.02 | 0.01 | -0.01 |
| Surprise Percentage | 87.5% | 350% | 2731.5789% | 10100% | 300% | 150% | 40% | 0% | 0% | 50% | 16.6667% | -50% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-12 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.11 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AVAH
2026-02-26 11:30:27
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that it will release its fourth quarter and full year 2025 results on Thursday, March 19, 2026, before the market open. The company will host a conference call on the same day at 10:00 a.m. Eastern Time to discuss the results, with replay options and a webcast available for interested investors.
2026-02-21 12:56:32
Hillsdale Investment Management Inc. has acquired a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), purchasing 893,130 shares valued at approximately $7.92 million in the third quarter. Despite this institutional buying, the company has seen significant insider selling from CEO Jeff Shaner and other executives, totaling nearly 1 million shares worth $7.57 million over the past 90 days, which has contributed to a recent stock pullback. Analysts currently rate Aveanna Healthcare as a "Hold" with an average target price of $11.06, while the stock trades around $7.34.
2026-02-21 01:47:27
Edwin C. Reisz, Chief Administrative Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), sold 161,043 shares of company stock for $1.19 million between February 17 and February 19, 2026. The sales were made to cover tax obligations from equity awards, leaving Reisz with 1,447,057 shares or about 0.9% of outstanding shares. Despite the insider sales and short-term stock weakness, the company has received positive analyst coverage and updated financial guidance, indicating potential undervaluation.
2026-02-21 00:19:54
Aveanna Healthcare Holdings Inc. has finalized new employment agreements for its CEO Jeff Shaner, CFO Matthew Buckhalter, and Chief Legal Officer Jerry Perchik, effective February 17, 2026. These agreements outline new base salaries, bonus structures, and severance packages for scenarios both with and without a change in control. The company also recently updated its financial outlook for 2025 and introduced 2026 projections, leading to positive analyst responses and increased price targets from firms like UBS, RBC Capital, and Raymond James.
2026-02-20 21:09:16
Aveanna Healthcare's Chief Accounting Officer, Deborah Stewart, sold 10,896 shares of the company's stock on February 18th, 2026, for a total of $80,412.48, reducing her ownership by 3.36%. This transaction is part of a larger trend of significant insider selling between February 17-19 by multiple executives, totaling approximately 740,000 shares worth $5.4-$5.5 million. The stock currently has a "Hold" rating from analysts with an average price target of $11.06, and the substantial insider selling may negatively impact investor sentiment in the near term.
2026-02-20 17:50:16
Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc., sold 49,160 shares of AVAH stock totaling approximately $363,068 between February 17 and February 19, 2026. These insider sales occurred as AVAH shares experienced a weekly decline but a significant yearly gain, and the company recently updated its financial guidance and received positive price target adjustments from several analyst firms.
